Homotypic protection against influenza in a pediatric cohort in Managua, Nicaragua
暂无分享,去创建一个
John Huddleston | R. Webby | E. Harris | M. Nelson | G. Kuan | A. Gordon | Á. Balmaseda | N. Sanchez | S. Ojeda | F. Carrillo | R. López | J. Kubale | A. Schiller | Steph Wraith | B. López | A. Balmaseda | J. Huddleston | Brenda López | Amy J Schiller | John T Kubale
[1] K. Koelle,et al. Lineage-specific protection and immune imprinting shape the age distributions of influenza B cases , 2020, Nature Communications.
[2] A. Gordon,et al. Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies , 2020, Proceedings of the National Academy of Sciences.
[3] A. Monto,et al. Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility , 2020, Nature Communications.
[4] L. Brammer,et al. The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century , 2019, PloS one.
[5] F. Krammer. The human antibody response to influenza A virus infection and vaccination , 2019, Nature Reviews Immunology.
[6] E. Lau,et al. Variation in Influenza B Virus Epidemiology by Lineage, China , 2018, Emerging infectious diseases.
[7] M. L. Matute,et al. Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014 , 2018, BMC Infectious Diseases.
[8] J. Peiris,et al. Age-specific differences in the dynamics of protective immunity to influenza , 2018, Nature Communications.
[9] Sarah Cobey,et al. Immune History and Influenza Vaccine Effectiveness , 2018, Vaccines.
[10] A. Gordon,et al. The Burden of Influenza: a Complex Problem , 2018, Current Epidemiology Reports.
[11] T. Ross,et al. Towards a universal influenza vaccine: different approaches for one goal , 2018, Virology Journal.
[12] Catharine I Paules,et al. The Pathway to a Universal Influenza Vaccine. , 2017, Immunity.
[13] Edward A Belongia,et al. Repeated annual influenza vaccination and vaccine effectiveness: review of evidence , 2017, Expert review of vaccines.
[14] S. Hensley,et al. Immune history and influenza virus susceptibility. , 2017, Current opinion in virology.
[15] S. McColl,et al. Vaccine‐Induced Antibody Responses Prevent the Induction of Interferon Type I Responses Upon a Homotypic Live Virus Challenge , 2016, Scandinavian journal of immunology.
[16] Trevor Bedford,et al. Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses , 2015, Proceedings of the National Academy of Sciences.
[17] E. Harris,et al. The Nicaraguan pediatric influenza cohort study: design, methods, use of technology, and compliance , 2015, BMC Infectious Diseases.
[18] Trevor Bedford,et al. Global circulation patterns of seasonal influenza viruses vary with antigenic drift , 2015, Nature.
[19] A. von Haeseler,et al. IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies , 2014, Molecular biology and evolution.
[20] P. Horby,et al. Determinants of Influenza Transmission in South East Asia: Insights from a Household Cohort Study in Vietnam , 2014, PLoS pathogens.
[21] A. Cook,et al. Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore , 2014, BMC Infectious Diseases.
[22] J. Wong,et al. Incidence of influenza virus infections in children in Hong Kong in a 3-year randomized placebo-controlled vaccine study, 2009-2012. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] K. Katoh,et al. MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.
[24] W. B. Church,et al. Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans , 2012, Immunology and cell biology.
[25] J. Oxford,et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans , 2012, Nature Medicine.
[26] T. Heikkinen,et al. Seasonal influenza: the burden of disease in children. , 2011, Vaccine.
[27] B. Johansson,et al. Recombinant Influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterovariant protection in mice than conventional and live influenza vaccines , 2008, Human vaccines.
[28] S. Epstein. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. , 2006, The Journal of infectious diseases.
[29] S. Itamura,et al. Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus. , 1991, The Journal of general virology.
[30] A. Frank,et al. Influenza B virus reinfection. , 1987, American journal of epidemiology.
[31] R B Couch,et al. Immunity to influenza in man. , 1983, Annual review of microbiology.
[32] A. Frank,et al. Variation in frequency of natural reinfection with influenza A viruses , 1983, Journal of medical virology.
[33] A. Monto,et al. Acute respiratory illness in an American community. The Tecumseh study. , 1974, JAMA.
[34] H. S. Kaye,et al. Studies on inactivated influenza vaccines. I. The effect of dosage on antibody response and protection against homotypic and heterotypic influenza virus challenge in mice. , 1969, American journal of epidemiology.